Hahm S H, Hsu C M, Eiden L E
Section on Molecular Neuroscience, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892-4090, USA.
J Mol Neurosci. 1998 Aug;11(1):43-56. doi: 10.1385/JMN:11:1:43.
Pituitary adenylate cyclase activating polypeptide-27 (PACAP-27) caused a dose-dependent increase in met-enkephalin secretion and increased production of met-enkephalin peptide and proenkephalin A (PEnk) mRNA in bovine chromaffin cells, at concentrations as low as 300 pM. PACAP-38 was less potent than PACAP-27, but had similar effects. Vasoactive intestinal polypeptide (VIP) (1-100 nM) was without appreciable effect on either enkephalin secretion or biosynthesis, implicating PACAP type I receptors in PACAP-stimulated enkephalin secretion and synthesis. PACAP type I receptors can activate adenylate cyclase and stimulate phospholipase C through heterotrimeric G protein interactions, leading to increased intracellular cyclic AMP (cAMP), inositol triphosphate (IP3)-mediated calcium mobilization, and calcium- and diacylglycerol (DAG)-mediated protein kinase C (PKC) activation. Enkephalin secretion evoked by 10-100 nM PACAP-27 was not inhibited by 1 microM (-)-202-791, an L-type specific dihydropyridine calcium channel blocker, but was inhibited 65-80% by the arylalkylamine calcium channel blocker D600. Forty mM potassium-evoked secretion was inhibited > 90% by both D600 and (-)-202-791, 25 microM forskolin-induced secretion was blocked < 50% by D600 and was unaffected by (-)-202-791, and 100 nM phorbol myristate acetate (PMA)-induced secretion was unaffected by either D600 or (-)-202-791. Enkephalin biosynthesis was increased by 10 nM PACAP-27, as measured by increased met-enkephalin pentapeptide content and PEnk A mRNA levels. PACAP-, forskolin-, and PMA-stimulated enkephalin synthesis were not blocked by D600 or (-)-202-791. Elevated potassium-induced enkephalin biosynthesis upregulation was completely blocked by either D600 or (-)-202-791 at the same concentrations. PACAP acting through type I PACAP receptors couples calcium influx-dependent enkephalin secretion and calcium influx-independent enkephalin biosynthesis in chromaffin cells. Restriction of the effects of enhanced calcium influx to stimulation of secretion, but not of biosynthesis, is unique to PACAP. By contrast, potassium-induced enkephalin biosynthesis upregulation is completely calcium influx dependent, specifically via calcium influx through L-type calcium channels. We propose that subpopulations of voltage-dependent calcium channels are differentially linked to intracellular signal transduction pathways that control neuropeptide gene expression and secretion in chromaffin cells.
垂体腺苷酸环化酶激活多肽 -27(PACAP -27)在牛嗜铬细胞中,即使浓度低至300 pM,也能引起甲硫氨酸脑啡肽分泌呈剂量依赖性增加,并增加甲硫氨酸脑啡肽肽和脑啡肽原A(PEnk)mRNA的产生。PACAP -38的效力低于PACAP -27,但具有相似的作用。血管活性肠肽(VIP)(1 - 100 nM)对脑啡肽的分泌或生物合成均无明显影响,这表明PACAP I型受体参与了PACAP刺激的脑啡肽分泌和合成。PACAP I型受体可通过异源三聚体G蛋白相互作用激活腺苷酸环化酶并刺激磷脂酶C,导致细胞内环状AMP(cAMP)增加、肌醇三磷酸(IP3)介导的钙动员以及钙和二酰基甘油(DAG)介导的蛋白激酶C(PKC)激活。10 - 100 nM PACAP -27诱发的脑啡肽分泌不受1 μM( - )-202 - 791(一种L型特异性二氢吡啶钙通道阻滞剂)的抑制,但被芳烷基胺钙通道阻滞剂D600抑制65 - 80%。40 mM钾诱发的分泌被D600和( - )-202 - 791均抑制> 90%,25 μM福斯可林诱导的分泌被D600阻断< 50%且不受( - )-202 - 791影响,100 nM佛波酯肉豆蔻酸酯(PMA)诱导的分泌不受D600或( - )-202 - 791影响。通过增加甲硫氨酸脑啡肽五肽含量和PEnk A mRNA水平测定,10 nM PACAP -27可增加脑啡肽的生物合成。PACAP、福斯可林和PMA刺激的脑啡肽合成不受D600或( - )-202 - 791的阻断。相同浓度下,D600或( - )-202 - 791可完全阻断高钾诱导的脑啡肽生物合成上调。通过I型PACAP受体起作用的PACAP在嗜铬细胞中耦合了钙内流依赖性脑啡肽分泌和钙内流非依赖性脑啡肽生物合成。将增强的钙内流的作用限制于刺激分泌而非生物合成,这是PACAP独有的。相比之下,钾诱导的脑啡肽生物合成上调完全依赖于钙内流,具体通过L型钙通道的钙内流。我们提出,电压依赖性钙通道的亚群与控制嗜铬细胞中神经肽基因表达和分泌的细胞内信号转导途径存在差异联系。